ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 575,62
-0,75%
Dow Jones
40 211,72
0,00%
DAX
18 496,55
-0,56%
Brent Oil
82,995
-1,59%
Bitcoin
64 063,93
-1,21%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioPlus Acquisition Corporation (BIOS)

  7. BioPlus Acquisition Corporation (BIOS) Actualités

BIOS

BioPlus Acquisition (BIOS)

BioPlus Acquisition Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BIOS
DateHeureSourceTitreSymboleSociété
22/10/201822h30GlobeNewswire Inc.BioScrip Appoints John McMahon as Chief Accounting OfficerNASDAQ:BIOSBioPlus Acquisition Corporation
05/09/201815h00GlobeNewswire Inc.BioScrip to Participate in Upcoming Investor ConferencesNASDAQ:BIOSBioPlus Acquisition Corporation
14/08/201823h06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BIOSBioPlus Acquisition Corporation
13/08/201822h07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BIOSBioPlus Acquisition Corporation
07/08/201814h21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
07/08/201814h03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
07/08/201814h00GlobeNewswire Inc.BioScrip Reports Second Quarter 2018 Financial ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
04/08/201800h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BIOSBioPlus Acquisition Corporation
30/07/201814h30GlobeNewswire Inc.BioScrip Appoints Leslie McIntosh as Chief Human Resources OfficerNASDAQ:BIOSBioPlus Acquisition Corporation
23/07/201822h30GlobeNewswire Inc.BioScrip to Present at the 38th Annual Canaccord Genuity Growth ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
18/07/201822h30GlobeNewswire Inc.BioScrip Schedules Release of Second Quarter 2018 Financial Results and Conference CallNASDAQ:BIOSBioPlus Acquisition Corporation
10/07/201814h30GlobeNewswire Inc.BioScrip Appoints Richard Denness as Chief Commercial OfficerNASDAQ:BIOSBioPlus Acquisition Corporation
10/05/201814h30GlobeNewswire Inc.BioScrip Reports First Quarter 2018 Financial ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
26/04/201822h30GlobeNewswire Inc.BioScrip Schedules Release of First Quarter 2018 Financial Results and Conference CallNASDAQ:BIOSBioPlus Acquisition Corporation
04/04/201813h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOSBioPlus Acquisition Corporation
26/03/201812h30GlobeNewswire Inc.BioScrip Timely Files Annual Form 10-K, Concludes Accounting Review and Provides Update on Immaterial Financial Statement Cor...NASDAQ:BIOSBioPlus Acquisition Corporation
26/03/201812h10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BIOSBioPlus Acquisition Corporation
15/03/201822h30Business WireBioScrip Provides Update on Annual Form 10-K Filing StatusNASDAQ:BIOSBioPlus Acquisition Corporation
15/03/201822h22Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:BIOSBioPlus Acquisition Corporation
08/03/201814h00Business WireBioScrip Reports Fourth Quarter and Full Year 2017 Financial ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
22/02/201814h00Business WireBioScrip Schedules Release of Fourth Quarter and Full Year 2017 Financial Results and Conference CallNASDAQ:BIOSBioPlus Acquisition Corporation
14/02/201823h59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSBioPlus Acquisition Corporation
09/02/201813h30Business WireBioScrip Announces U.S. Congress Passage of Medicare Home Infusion Transition Benefit, Effective 2019NASDAQ:BIOSBioPlus Acquisition Corporation
01/02/201815h29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOSBioPlus Acquisition Corporation
08/01/201814h00GlobeNewswire Inc.BioScrip Announces Availability of HEMLIBRA® for Hemophilia PatientsNASDAQ:BIOSBioPlus Acquisition Corporation
30/11/201714h00GlobeNewswire Inc.BioScrip to Host Meetings at the Mizuho Investor ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
28/11/201714h00GlobeNewswire Inc.BioScrip Announces Additions to Senior Leadership TeamNASDAQ:BIOSBioPlus Acquisition Corporation
16/11/201715h00GlobeNewswire Inc.BioScrip to Present at Bank of America Merrill Lynch 2017 Leveraged Finance ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
09/11/201714h00GlobeNewswire Inc.BioScrip to Host Meetings at the 8th Annual Craig-Hallum Alpha Select ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
02/11/201718h13Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BIOSBioPlus Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BIOS

Dernières Valeurs Consultées

BIT
P1Y201
NLBNPIT1Y201 20240920 3.2
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés